Rishi Gupta - Net Worth and Insider Trading
Rishi Gupta Net Worth
The estimated net worth of Rishi Gupta is at least $247 Million dollars as of 2024-06-05. Rishi Gupta is the Director, 10% Owner of Enliven Therapeutics Inc and owns about 7,663,349 shares of Enliven Therapeutics Inc (ELVN) stock worth over $160 Million. Rishi Gupta is the Director of Verona Pharma PLC and owns about 3,777,778 shares of Verona Pharma PLC (VRNA) stock worth over $46 Million. Rishi Gupta is also the Director, 10% Owner of Dimension Therapeutics Inc and owns about 5,397,698 shares of Dimension Therapeutics Inc (DMTX) stock worth over $32 Million. Besides these, Rishi Gupta also holds Turnstone Biologics Corp (TSBX) . Details can be seen in Rishi Gupta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rishi Gupta has not made any transactions after 2024-05-16 and currently still holds the listed stock(s).
Transaction Summary of Rishi Gupta
Rishi Gupta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rishi Gupta owns 6 companies in total, including Dimension Therapeutics Inc (DMTX) , Sientra Inc (SIENQ) , and ChemoCentryx Inc (CCXI) among others .
Click here to see the complete history of Rishi Gupta’s form 4 insider trades.
Insider Ownership Summary of Rishi Gupta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMTX | Dimension Therapeutics Inc | 2016-05-19 | director |
| SIENQ | Sientra Inc | 2014-10-28 | director & 10 percent owner |
| CCXI | ChemoCentryx Inc | 2012-02-08 | director |
 | | 2023-05-15 | director & 10 percent owner |
| | 2024-05-16 | director & 10 percent owner |
| | 2023-07-20 | director & 10 percent owner |
Rishi Gupta Latest Holdings Summary
Rishi Gupta currently owns a total of 4 stocks. Among these stocks, Rishi Gupta owns 7,663,349 shares of Enliven Therapeutics Inc (ELVN) as of May 16, 2024, with a value of $160 Million and a weighting of 64.96%. Rishi Gupta owns 3,777,778 shares of Verona Pharma PLC (VRNA) as of May 15, 2023, with a value of $46 Million and a weighting of 18.51%. Rishi Gupta also owns 5,397,698 shares of Dimension Therapeutics Inc (DMTX) as of October 27, 2015, with a value of $32 Million and a weighting of 13.01%. The other 1 stocks Turnstone Biologics Corp (TSBX) have a combined weighting of 3.53% among all his current holdings.
Latest Holdings of Rishi Gupta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics Inc | 2024-05-16 | 7,663,349 | 20.93 | 160,393,895 |
| VRNA | Verona Pharma PLC | 2023-05-15 | 3,777,778 | 12.10 | 45,711,114 |
| DMTX | Dimension Therapeutics Inc | 2015-10-27 | 5,397,698 | 5.95 | 32,116,303 |
| TSBX | Turnstone Biologics Corp | 2023-07-20 | 3,099,265 | 2.81 | 8,708,935 |
Holding Weightings of Rishi Gupta
Rishi Gupta Form 4 Trading Tracker
According to the SEC Form 4 filings, Rishi Gupta has made a total of 1 transactions in Enliven Therapeutics Inc (ELVN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Enliven Therapeutics Inc is the sale of 1,033,300 shares on May 16, 2024, which brought Rishi Gupta around $23 Million.
According to the SEC Form 4 filings, Rishi Gupta has made a total of 2 transactions in Verona Pharma PLC (VRNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Verona Pharma PLC is the sale of 482,913 shares on May 15, 2023, which brought Rishi Gupta around $10 Million.
According to the SEC Form 4 filings, Rishi Gupta has made a total of 0 transactions in Dimension Therapeutics Inc (DMTX) over the past 5 years. The most-recent trade in Dimension Therapeutics Inc is the acquisition of 200,000 shares on October 27, 2015, which cost Rishi Gupta around $3 Million.
More details on Rishi Gupta's insider transactions can be found in the Insider Trading History of Rishi Gupta table.Insider Trading History of Rishi Gupta
- 1
Rishi Gupta Trading Performance
GuruFocus tracks the stock performance after each of Rishi Gupta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rishi Gupta is -39.93%. GuruFocus also compares Rishi Gupta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rishi Gupta within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rishi Gupta's insider trading performs compared to the benchmark.
Performance of Rishi Gupta
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.98 | | | | | |
| Relative Return to S&P 500(%) | 11.81 | | | | | |
Rishi Gupta Ownership Network
Rishi Gupta Owned Company Details
What does Dimension Therapeutics Inc do?
Who are the key executives at Dimension Therapeutics Inc?
Rishi Gupta is the director of Dimension Therapeutics Inc. Other key executives at Dimension Therapeutics Inc include other: See Remark 1 Fmr Llc , director & President and CEO Annalisa Jenkins , and Chief Operating Officer Mary Thistle .
Dimension Therapeutics Inc (DMTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dimension Therapeutics Inc (DMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dimension Therapeutics Inc (DMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dimension Therapeutics Inc (DMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dimension Therapeutics Inc Insider Transactions
Rishi Gupta Mailing Address
Above is the net worth, insider trading, and ownership report for Rishi Gupta. You might contact Rishi Gupta via mailing address: C/o Chemocentryx, Inc., 850 Maude Avenue, Mountain View Ca 94043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
